Extracted Page: http://act-ad.org/

November 6, 2014 - SAVE THE DATE! ACT-AD will host its 7th FDA/Alzheimer’s Disease Allies Meeting for patient groups, regulators, researchers and industry at the Bethesda North Marriott Hotel & Conference Center (5701 Marinelli Rd, Bethesda, MD 20852). This meeting will explore challenges related to clinical meaningfulness in therapeutic development for early Alzheimer’s disease. (More Info)

Today Alzheimer's disease, or AD, is a fatal diagnosis with death preceded by a slow, painful decline and loss of quality of life. The ACT-AD Coalition believes we have the ability to vastly improve the outlook for people with AD and thier caregivers in the next decade and we are committed to working with a diverse group of stakeholders to Accelerate a Cure and Treatments for Alzheimer's Disease. (More Info)

July 1, 2014 ––BIO 2014′s session titled "Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move Toward Earlier Detection and Intervention, How Will Researchers Adapt to this Evolution?” discussed progress and challenges facing researchers and the collaborative efforts between the Food and Drug Administration (FDA) and patient advocacy groups to help them find a cure. The discussion centered on recent FDA Draft Guidance for Early Stage Alzheimer’s Disease Drug Development which allows for an accelerated approval process for drugs which show that they have an effect on cognition, which is an early indicator of the disease. The session featured the work of ACT-AD.(More Info)

Domino Data Lab Home Page ... Welcome ! ! !

Domino Data Lab Home Page ... Welcome ! ! !

Login to your brain

Create account